Folkers K - Search Results

1

Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.

Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Mortensen SA, et al. Among authors: folkers k. Drugs Exp Clin Res. 1985;11(8):581-93. Drugs Exp Clin Res. 1985. PMID: 3836876

2

Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.

Langsjoen PH, Vadhanavikit S, Folkers K. Langsjoen PH, et al. Among authors: folkers k. Drugs Exp Clin Res. 1985;11(8):577-9. Drugs Exp Clin Res. 1985. PMID: 3836875 Clinical Trial.

3

Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.

Folkers K, Vadhanavikit S, Mortensen SA. Folkers K, et al. Proc Natl Acad Sci U S A. 1985 Feb;82(3):901-4. doi: 10.1073/pnas.82.3.901. Proc Natl Acad Sci U S A. 1985. PMID: 3856239 Free PMC article.

4

Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.

Langsjoen PH, Vadhanavikit S, Folkers K. Langsjoen PH, et al. Among authors: folkers k. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4240-4. doi: 10.1073/pnas.82.12.4240. Proc Natl Acad Sci U S A. 1985. PMID: 3858877 Free PMC article. Clinical Trial.

5

Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.

Folkers K, Wolaniuk J, Simonsen R, Morishita M, Vadhanavikit S. Folkers K, et al. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4513-6. doi: 10.1073/pnas.82.13.4513. Proc Natl Acad Sci U S A. 1985. PMID: 3859873 Free PMC article. Clinical Trial.

6

Micro-analysis for coenzyme Q10 in endomyocardial biopsies of cardiac patients and data on bovine and canine hearts.

Vadhanavikit S, Morishita M, Duff GA, Folkers K. Vadhanavikit S, et al. Among authors: folkers k. Biochem Biophys Res Commun. 1984 Sep 28;123(3):1165-9. doi: 10.1016/s0006-291x(84)80255-7. Biochem Biophys Res Commun. 1984. PMID: 6487325

7

Quantitative determination of coenzyme Q10 in human blood for clinical studies.

Vadhanavikit S, Sakamoto N, Ashida N, Kishi T, Folkers K. Vadhanavikit S, et al. Among authors: folkers k. Anal Biochem. 1984 Oct;142(1):155-8. doi: 10.1016/0003-2697(84)90530-x. Anal Biochem. 1984. PMID: 6517310

8

Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure.

Mortensen SA, Vadhanavikit S, Muratsu K, Folkers K. Mortensen SA, et al. Among authors: folkers k. Int J Tissue React. 1990;12(3):155-62. Int J Tissue React. 1990. PMID: 2276893 Review.

9

Hemostatic changes after dietary coenzyme Q10 supplementation in swine.

Serebruany VL, Herzog WR, Atamas SP, Gurbel PA, Rohde M, Mortensen SA, Folkers K. Serebruany VL, et al. Among authors: folkers k. J Cardiovasc Pharmacol. 1996 Aug;28(2):175-81. doi: 10.1097/00005344-199608000-00001. J Cardiovasc Pharmacol. 1996. PMID: 8856471

10

Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.

Serebruany VL, Ordonez JV, Herzog WR, Rohde M, Mortensen SA, Folkers K, Gurbel PA. Serebruany VL, et al. Among authors: folkers k. J Cardiovasc Pharmacol. 1997 Jan;29(1):16-22. doi: 10.1097/00005344-199701000-00003. J Cardiovasc Pharmacol. 1997. PMID: 9007665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters